Citation Impact
Citing Papers
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
Epidemic Visceral Leishmaniasis in Sudan: A Randomized Trial of Aminosidine plus Sodium Stibogluconate versus Sodium Stibogluconate Alone
1993
Leishmaniasis
2018 Standout
Ribosomes ofLeishmania are a target for the aminoglycosides
1995
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
2006
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
A policy for leishmaniasis with respect to the prevention and control of drug resistance
2001
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Natural products: An evolving role in future drug discovery
2011 Standout
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
2000
Effect of Performance Improvement Programs on Compliance with Sepsis Bundles and Mortality: A Systematic Review and Meta-Analysis of Observational Studies
2015
Practical progress and new drugs for changing patterns of leishmaniasis
1993
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India Commentary: Some good news for treatment of visceral leishmaniasis in Bihar
1998
Paromomycin
2008
Cutaneous leishmaniasis
2007 Standout
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
2003
Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica
1994
Challenges and new discoveries in the treatment of leishmaniasis
2004
Combination therapy for visceral leishmaniasis
2010
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
2006 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Injectable Paromomycin for Visceral Leishmaniasis in India
2007
3. Visceral leishmaniasis
2001
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
2000
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study
2010
Control of Neglected Tropical Diseases
2007 Standout
Leishmaniasis
1999 Standout
A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA
2005
Antiamoebic drugs for treating amoebic colitis
2009
Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis
1994
Treatment of Kala-Azar in Southern Sudan using a 17-Day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-Day Sodium Stibogluconate Monotherapy
2007
Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis
2000
A Critical Review on Chagas Disease Chemotherapy
2002 Standout
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Treatment options for visceral leishmaniasis
2006
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Advances in leishmaniasis
2005 Standout
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin B-lipid complex
1998
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs
2005
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex
1998
Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control
2006 Standout
Antimony Toxicity
2010
Drug Resistance in Leishmaniasis
2006 Standout
Works of L Donno being referenced
Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate
1990
Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study
2009
Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya
1990